Kai Lovis
12Patents
2h-index
40Co-inventors
50Inventor score
Filing activity: Mar 27, 2002 → Dec 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10035803B2 | Synthesis of copanlisib and its dihydrochloride salt | Chemistry; Metallurgy | 7 | Active |
| US7067683B2 | Industrially applicable process for the sulfamoylation of alcohols and phenols | Chemistry; Metallurgy | 3 | Expired |
| US10905667B2 | Orally administrable modified-release pharmaceutical dosage form | Chemistry; Metallurgy | 2 | Active |
| US10494372B2 | Synthesis of copanlisib and its dihydrochloride salt | Chemistry; Metallurgy | 2 | Active |
| US12054481B2 | Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide by racemate separation by means of diastereomeric tartaric acid esters | Chemistry; Metallurgy | 1 | Active |
| US6652782B1 | Multi-stage method for producing gas-filled microcapsules | Emerging Cross-Sectional Technologies | 1 | Expired |
| US12398144B2 | Photochemical process for producing (4R,4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxamide | Chemistry; Metallurgy | 0 | Active |
| US11332435B2 | Method for producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4- chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredient | Emerging Cross-Sectional Technologies | 0 | Active |
| US12365679B2 | Process for producing acyloxymethyl esters of (4S)-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxylic acid | Chemistry; Metallurgy | 0 | Active |
| US9359306B2 | Process for preparing pan-CDK inhibitors of the formula (I), and intermediates in the preparation | Emerging Cross-Sectional Technologies | 0 | Active |
| US11344519B2 | Orally administrable modified-release pharmaceutical dosage form | Chemistry; Metallurgy | 0 | Active |
| US12358877B2 | Synthesis of 4-amino-5-methyl-1H-pyridin-2(1H)-on (intermediate compound for the synthesis of the MR antagonist finerenone) from 2-chloro-5-methyl-4-nitro-pyridine-1-oxide using the intermediate compound 2-chloro-5-methyl-4-pyridinamine | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.